Arecor Therapeutics (LSE:AREC) Pre-Tax Income : £-8.90 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Arecor Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Arecor Therapeutics's pretax income for the six months ended in Dec. 2023 was £-4.10 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was £-8.90 Mil. Arecor Therapeutics's pretax margin was -141.18%.

During the past 7 years, Arecor Therapeutics's highest Pretax Margin was -105.63%. The lowest was -599.74%. And the median was -295.26%.

Arecor Therapeutics Pre-Tax Income Historical Data

The historical data trend for Arecor Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arecor Therapeutics Pre-Tax Income Chart

Arecor Therapeutics Annual Data

Trend

May17

May18

May19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-2.87

-3.51

-6.95

-10.42

-8.90

Arecor Therapeutics Semi-Annual Data
	May18	May19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial					-3.49	-5.23	-5.19	-4.80	-4.10

Competitive Comparison of Arecor Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Arecor Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arecor Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arecor Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Arecor Therapeutics's Pre-Tax Income falls into.

Arecor Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Arecor Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-9.175	+	0	+	-0.015	+	0.284	+	0.0050000000000008
	=	-8.90

Arecor Therapeutics's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-4.22	+	0	+	-0.005	+	0.12	+	0.0049999999999999
	=	-4.10

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-8.90 Mil.

Arecor Therapeutics (LSE:AREC) Pre-Tax Income Explanation

Arecor Therapeutics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-4.1	/	2.904
	=	-141.18%

During the past 7 years, Arecor Therapeutics's highest Pretax Margin was -105.63%. The lowest was -599.74%. And the median was -295.26%.

Arecor Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Arecor Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Arecor Therapeutics (LSE:AREC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arecor Therapeutics PLC (LSE:AREC) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

6UI:Germany

Address

Chesterford Research Park, Little Chesterford, Saffron Walden, GBR, CB10 1XL

Website

https://www.arecor.com

Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, the Rest of Europe, the USA, India, and the Rest of the World, out of which the majority is from the UK.